CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 272 filers reported holding CUBIST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $273,775,000 | +20.6% | 2,720,073 | -20.5% | 1.61% | +16.2% |
| Q3 2014 | $226,978,000 | +0.5% | 3,421,430 | +5.8% | 1.39% | +3.1% |
| Q2 2014 | $225,838,000 | +14.4% | 3,234,570 | +19.9% | 1.34% | +13.8% |
| Q1 2014 | $197,376,000 | +6.0% | 2,698,235 | -0.2% | 1.18% | +7.8% |
| Q4 2013 | $186,191,000 | +60.5% | 2,703,519 | +48.1% | 1.10% | +47.9% |
| Q3 2013 | $115,987,000 | +51.0% | 1,825,134 | +14.7% | 0.74% | +40.3% |
| Q2 2013 | $76,838,000 | – | 1,591,179 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quinn Opportunity Partners LLC | 328,000 | $33,013,000 | 15.74% |
| Cheyne Capital Management (UK) LLP | 373,372 | $37,593,000 | 9.88% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 897,136 | $90,296,000 | 9.71% |
| Andromeda Capital LLC | 76,760 | $7,726,000 | 9.71% |
| Palo Alto Investors LP | 1,303,668 | $131,214,000 | 7.70% |
| Andromeda Capital LLC | 50,000 | $5,033,000 | 6.32% |
| QVT Financial LP | 1,200,000 | $120,780,000 | 6.04% |
| HARVEST MANAGEMENT LLC | 42,500 | $4,278,000 | 6.03% |
| Sandell Investment Services LLC | 58,525 | $5,891,000 | 5.62% |
| Kellner Capital, LLC | 70,200 | $7,066,000 | 4.83% |